Fri, Jul 25, 2014, 8:26 AM EDT - U.S. Markets open in 1 hr 4 mins

Recent

% | $
Click the to save as a favorite.

Omeros Corporation (OMER) Message Board

  • rrtzrealmd rrtzrealmd Mar 31, 2013 7:56 PM Flag

    In that seekingalpha article...

    ...I particularly enjoyed the comments from the retired ophthalmologist, "eyekew":

    "1) Their website gives no real information either about the drug (the rationale for developing it, it's competitive advantages, patent protection, marketing plans, etc.). The people associated with Omeros seem to ave good backgrounds.

    2) I coud find nothing in the eye literature. Usually, if there is a really helpful drug/device on the horizon there is some buzz. All mentions were in investing media with the exception of 1 on WebMD. That one was sponsored by the company and authored by one of it's officers, i.e. no outside evaluation, no double blind studies. The studies mentioned fail to show any increased efficacy over currently used and very inexpensive drugs."

    ...boy, is he dumb or what?...worrying about things like "efficacy over currently used and very inexpensive drugs"!...HAW!!!...

    ...silly man!...he clearly doesn't understand that the "rationale for developing it" is to scam naive investors...

    ...that's why there is no "marketing plan" -- because they likely never intended to market anything!...

    ...and since they likely never planned on marketing anything, there wasn't any need to worry about patent protection or "competitive advantages"...

    ...quod erat demonstrandum!...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OMER
14.05-0.30(-2.09%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.